El-MoftySK: Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: An update with special reference to HPV-related carcinomas. Med Oral Patol Oral Cir Bucal, 2014; 19:e377–e385.
2.
AhdiehL, KleinRS, BurkR, Cu-UvinS, SchumanP, DuerrA, SafaeianM, AstemborskiJ, DanielR, ShahK: Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis, 2001; 184:682–690.
3.
MussiniC, LorenziniP, Cozzi-LepriA, LapadulaG, MarchettiG, NicastriE, CingolaniA, LichtnerM, AntinoriA, GoriA, d'Arminio MonforteA; Icona Foundation Study Group: CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study. Lancet HIV, 2015; 2:e98–e106.
4.
JouraEA, GarlandSM, PaavonenJ, FerrisDG, PerezG, AultKA, HuhWK, SingsHL, JamesMK, HauptRM: Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ, 2012; 344:e1401.
